JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vaillant, G. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vaillant, G. E.
Journal of Pharmacology And Experimental Therapeutics, Vol. 157, Issue 3, 636-648, 1967
Copyright © 1967 by American Society for Pharmacology and Experimental Therapeutics


A COMPARISON OF ANTAGONISTS OF PHYSOSTIGMINE-INDUCED SUPPRESSION OF BEHAVIOR

George E. Vaillant 1

1 Department of Pharmacology, Harvard Medical School, Boston, Massachusetts

Experiments were designed to assess the effects of a variety of drugs in antagonizing the suppression of operant behavior by physostigmine. The experimental preparations were pigeons and monkeys pretreated both with physostigmine and with methylatropine; the latter drug was given to block peripheral effects of physostigmine. The operant behavior was maintained on fixed interval and fixed ratio schedules by food reinforcement or shock termination. Previous observations that physostigmine exerted a very nonspecific suppressant effect upon operant behavior were confirmed; the observed effects seemed mediated by a muscarine-like effect of physostigmine on the central nervous system. Physostigmine-induced suppression of behavior was not differentially affected by type of schedule or by type of reinforcer. Scopolamine, atropine, trihexyphenidyl, benztropine, diphenhydramine and imipramine antagonized physostigmine-induced suppression at dose levels comparable to those known to antagonize acetylcholine in the periphery and those producing sedative effects in humans. Chlorpromazine, dihydro-beta-erythroidine, mecamylamine and amphetamine proved ineffective in reversing physostigmine-induced suppression of behavior.

Submitted on November 30, 1966
Accepted on May 2, 1967




This article has been cited by other articles:


Home page
Arch Gen PsychiatryHome page
D. S. Janowsky, M. K. EI-Yousef, J. M. Davis, and H. J. Sekerke
Parasympathetic Suppression of Manic Symptoms by Physostigmine
Arch Gen Psychiatry, April 1, 1973; 28(4): 542 - 547.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1967 by the American Society for Pharmacology and Experimental Therapeutics.